Revenue

With a 61% profit surge, the Dutch tank storage giant rewards investors while launching a €4B plan to dominate both traditional and green energy infrastructure.

New research reveals how stomach cancer cells hijack healthy tissue to build supportive 'nests' in distant organs, opening a new front in the war on metastasis.

The diabetes tech firm secures major funding for innovation and acquisitions, using a savvy financial strategy to protect current shareholder value.

Amid market volatility, QuickFund AI offers traders structured capital. But can its model of discipline over speculation deliver on its promise?

A leading Indian tour company is breaking barriers by training women as long-distance chauffeurs, a move redefining tourism and empowering communities.

The global logistics giant didn't just win awards; it validated a strategy that merges sustainability with financial performance and investor trust.

Fox ESS unveils its powerful H3 PRO hybrid inverter, a scalable solution designed to accelerate Australia's rapid shift to a storage-led energy future.

Amid retail uncertainty, Gap Inc. raises its quarterly dividend by 6%, a move backed by strong financials and a bullish Wall Street outlook.

A new tech startup is launching an AI platform to replace high-pressure sales with transparent pricing, promising to cut homeowners' roof costs by up to 50%.

New FDA-cleared Persona PLUS technology promises to increase plasma yields per donor, tackling the growing global demand for life-saving therapies.

The healthcare specialist reported a staggering 2025 net loss due to a write-down, but projects 30% revenue growth fueled by new contracts.

Promising trial data for onvansertib offers new hope for colorectal cancer patients, yet leadership changes and financial hurdles cloud the path forward.

Shipping giant Matson posts strong Q4 results, buoyed by e-commerce and a stable US-China trade deal, and charts a course for growth with a $425M investment.

NWPX Infrastructure acquires 50-year-old Boughton's Precast, establishing a key manufacturing hub in Colorado to capitalize on surging infrastructure demand.

Amid private credit turmoil, SLR Investment Corp. posts solid 2025 results, leveraging a strategic pivot to asset-based lending for stability and returns.

Heritage Insurance projects a stunning full-year return on equity over 45%, setting the stage for a blockbuster earnings report on March 9.

Navitas Semiconductor accepts short-term losses for a future in AI data centers and energy, signaling a major shift in the power electronics landscape.

Archrock crushes profit estimates and hikes its dividend, signaling strong confidence as it positions to power the soaring energy demands of LNG and AI.

The biotech firm secures major funding to push its promising head and neck cancer drug, ficerafusp alfa, toward regulatory approval and commercial launch.

The life sciences giant's significant dividend hike underscores its robust financial health and commitment to growth, even as it pursues major acquisitions.